| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 13 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 3 | PACLITAXEL | 13 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 13 |
| 5 | PEMBROLIZUMAB | 13 |
| 6 | CARBOPLATIN | 11 |
| 7 | EPIRUBICIN HYDROCHLORIDE | 9 |
| 8 | ESOMEPRAZOLE MAGNESIUM | 8 |
| 9 | PANTOPRAZOLE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMOXAPINE | 1 | 0.0021 |
| 1 | EPIRUBICIN HYDROCHLORIDE | 9 | 0.0014 |
| 2 | DATOPOTAMAB DERUXTECAN | 1 | 0.0012 |
| 3 | LASMIDITAN | 1 | 0.0009 |
| 4 | CEFUROXIME SODIUM | 1 | 0.0008 |
| 5 | HYDROCORTISONE SODIUM SUCCINATE | 3 | 0.0008 |
| 6 | LEMBOREXANT | 2 | 0.0007 |
| 7 | NALDEMEDINE | 1 | 0.0006 |
| 8 | ALBENDAZOLE | 1 | 0.0005 |
| 9 | OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 2 | Anthelmintic [EPC] | 1 | 0.0003 |
| 3 | GLP-2 Analog [EPC] | 4 | 0.0003 |
| 4 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Bismuth [EPC] | 1 | 0.0002 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 16 | 0.0002 |
| 7 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |
| 8 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 9 | Orexin Receptor Antagonist [EPC] | 2 | 0.0001 |